This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Medgenn (Hong Kong) Ltd. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Qingxin Lei: Innovator in Cancer Treatment
Introduction
Qingxin Lei is a notable inventor based in Beijing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Qingxin Lei holds a patent for "Methods of treating cancer using a modified endostatin protein." This invention provides methods for treating angiogenesis-related diseases by utilizing a therapeutically effective amount of a modified endostatin protein. The methods include the use of this modified endostatin in combination with known cancer therapy agents, such as chemotherapy or radiotherapy agents.
Career Highlights
Throughout his career, Qingxin Lei has worked with prominent organizations, including Medgenn (Hong Kong) Ltd and Tsinghua University. His work has focused on advancing cancer treatment methodologies and improving patient outcomes.
Collaborations
Qingxin Lei has collaborated with esteemed colleagues, including Yongzhang Luo and Zhuobing Zhang. These partnerships have contributed to the development of innovative solutions in the medical field.
Conclusion
Qingxin Lei's work in cancer treatment exemplifies the impact of innovation in healthcare. His patented methods and collaborations highlight his commitment to advancing medical science and improving the lives of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile